Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second p ...

Royal Bank of Canada reaffirmed their outperform rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...

A Toowoomba resident came face-to-face with a redicivist criminal who has spent a majority of his adult life serving jail ...

Investment analysts at William Blair dropped their Q1 2025 EPS estimates for shares of CARGO Therapeutics in a research note issued to investors on Thursday, March 13th. William Blair analyst S.

MARACAIBO – Jhoan Bastidas was deported from the United States and spent 16 days at the U.S. naval base in Guantanamo Bay, ...

The crown jewel of El Salvador’s aggressive anti-crime strategy is a mega-prison where visitation, recreation and education ...

Because the GLC is their best-selling model, Mercedes is changing its electric strategy for it. Instead of making compromises ...

How is Aadhaar-EPIC linking relevant to the UPSC exam? What significance do topics like CAR T-cell therapy, smart cities ...

The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 ...